Vital Farms sees 2026 net revenue of $775 mln to $800 mln
Company expects 2026 adjusted EBITDA of $0 mln to $10 mln
Capital expenditures for 2026 expected at $70 mln to $75 mln
Overview
U.S. pasture-raised egg producer's Q2 revenue fell 10% yr/yr but beat analyst expectations
Adjusted EBITDA loss for Q2 widened and missed analyst estimates
Company announced new $185 mln credit facilities and terminated stock repurchase program
Key details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$166.03 mln
$160.23 mln (9 Analysts)
Q2 Net Loss
$31.07 mln
Q2 Adjusted EBITDA
Miss
-$26.60 mln
-$20.75 mln (8 Analysts)
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food retail & distribution peer group is "buy."
Wall Street's median 12-month price target for Vital Farms Inc is $12.00, about 2% below its August 5 closing price of $12.24
VITL•
